| MR编号 | NL/H/3136/001 |
|---|
| 药品名称 | Tiotropium bromide lnpresgo 18 microgram, inhalation powder, hard capsule |
|---|
| 活性成分 | - tiotropium bromide 18.0 µg
|
|---|
| 剂型 | Inhalation powder, hard capsule |
|---|
| 上市许可持有人 | Boehringer Ingelheim International GmbH
Binger Strasse 173
55216 Ingelheim am Rhein
Germany |
|---|
| 参考成员国 - 产品名称 | Netherlands (NL) Favynd Inpresgo 18 microgram, inhalatiepoeder in harde capsules |
|---|
| 互认成员国 - 产品名称 | - Hungary (HU)
- Slovenia (SI)
- Luxembourg (LU)
- United Kingdom (Northern Ireland) (XI)
- France (FR)
- Italy (IT)
- Lithuania (LT)
Favynd 18 mikrogramų įkvepiamieji milteliai (kietosios kapsulės) - Cyprus (CY)
FAVYND INPRESGO 18 microgram, inhalation powder, hard capsule - Malta (MT)
- Romania (RO)
- Belgium (BE)
- Sweden (SE)
- Norway (NO)
- Denmark (DK)
- Iceland (IS)
- Ireland (IE)
- Finland (FI)
- Poland (PL)
- Latvia (LV)
|
|---|
| 许可日期 | 2015/06/24 |
|---|
| 最近更新日期 | 2024/08/19 |
|---|
| 药物ATC编码 | - R03BB04 tiotropium bromide
|
|---|
| 申请类型 | - TypeLevel1：Known Active Substance
- TypeLevel2：Initial Application
- TypeLevel3：Full Dossier Art 8.3(i) Dir 2001/83/EC
- TypeLevel4：Chemical Substance
- TypeLevel5：Prescription Only
|
|---|
| 附件文件下载 | |
|---|
| 市场状态 | Positive |
|---|